300006 Chongqing Lummy Pharmaceutical
- 5.56
- +0.10+1.83%
Chongqing Lummy Pharmaceutical News
Laimei Pharmaceutical: Announcement on Transfer of Shares in Sichuan Hezheng Pharmaceutical Co., Ltd.
Laimei Pharmaceutical: 1 Response from the applicant and sponsor agency (revised draft)
Laimei Pharmaceutical: Additional Legal Opinions from 3 Law Firms (Revised Draft)
Laimei Pharmaceutical: Announcement on Transfer of Shares in Chongqing Laimei Health Industry Co., Ltd.
Laimei Pharmaceutical: Issuance of registration process feedback implementation letter
Laimei Pharmaceutical: Announcement on Adjusting the Asset Disposal Plan
Laimei Pharmaceutical: 1 Response from the applicant and sponsor agency (revised draft)
Laimei Pharmaceutical: Additional Legal Opinions from 3 Law Firms (Revised Draft)
Laimei Pharmaceutical: Implementation letter from the Audit Center on Chongqing Laimei Pharmaceutical Co., Ltd.'s application to issue shares to specific targets
Laimei Pharmaceutical: Announcement on the progress of the public listing and transfer of the company's assets
Laimei Pharmaceutical: 3-1 Securities Issuance Sponsorship Letter (Declaration Draft)
Laimei Pharmaceutical: 2 Accounting Firm Responses to Comments (Second Revised Draft)
Laimei Pharmaceutical: 1 Response from the applicant and sponsor agency (three revised drafts)
Laimei Pharmaceutical: 3-3 Listing Sponsorship Letter (Application Draft)
Laimei Pharmaceutical: Additional Legal Opinions from 3 Law Firms (Three Revisions)
Laimei Pharmaceutical: 1-1 Application Instructions (Application Draft)
Laimei Pharmaceutical: 3-3 Listing Sponsorship Letter (Application Draft)
Laimei Pharmaceutical: Additional Legal Opinions from 3 Law Firms (Second Revised Draft)
Laimei Pharmaceutical: 1-1 Application Instructions (Application Draft)
Laimei Pharmaceutical: 1 Response from the applicant and sponsor agency (Second revised draft)
Analysis
Price Target
No Data
No Data